| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/25/2009 | US20090162390 Molecular Scaffolds for HIV-1 Immunogens |
| 06/25/2009 | US20090162385 Compositions for and methods of enhancing the immune response to antigens |
| 06/25/2009 | US20090162383 Method for designing vaccines against constantly mutating pathogens |
| 06/25/2009 | US20090162376 Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints |
| 06/25/2009 | US20090162368 Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acids |
| 06/25/2009 | US20090162367 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/25/2009 | US20090162365 Novel siRNAS and methods of use thereof |
| 06/25/2009 | US20090162363 Pedf-r receptor and uses |
| 06/25/2009 | US20090162361 Method for diagnosing pancreatic cancer |
| 06/25/2009 | US20090162351 Transdiscal administration of inhibitors of p38 MAP kinase |
| 06/25/2009 | US20090162349 Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels |
| 06/25/2009 | US20090162347 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/25/2009 | US20090162341 For inhibition or reduction of exocytic fusion in a nociceptive sensory afferent cell comprising a Targeting Moiety, a non-cytotoxic protease and a Translocation Domain; pain |
| 06/25/2009 | US20090162338 Inhibiting metastasis of cancer cells by administering a phosphatidyl inositol 3-kinase inhibitor such as Wortmannin or LY294002 (2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one) |
| 06/25/2009 | US20090162335 Melatonin and immunostimulating substance-based compositions |
| 06/25/2009 | US20090162333 Pharmaceutical composition comprising apolipoproteins for the treatment of human diseases |
| 06/25/2009 | US20090162332 Methods and compositions for treating brain diseases |
| 06/25/2009 | US20090162319 Reverse transcriptase inhibitors |
| 06/25/2009 | US20090162318 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors |
| 06/25/2009 | US20090162314 Magnesium-Containing Polymers for the Treatment of Hyperphosphatemia |
| 06/25/2009 | US20090162313 High-Molecular Weight Conjugate of Podophyllotoxins |
| 06/25/2009 | US20090162312 Novel biodegradable biofouling control coating and method of formulation |
| 06/25/2009 | US20090162311 Agent for Prevention and/or Treatment of Glomerulopathy |
| 06/25/2009 | US20090162305 Formulations of low oil content comprising diphenylmethane derivatives |
| 06/25/2009 | US20090162303 Composition containing two polyesters |
| 06/25/2009 | US20090162301 Antiseptic Compositions |
| 06/25/2009 | US20090162300 Buccal, polar and non-polar spray containing alprazolam |
| 06/25/2009 | US20090162299 Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer |
| 06/25/2009 | US20090162298 Buccal, polar and non-polar spray containing sumatriptan |
| 06/25/2009 | US20090162297 Buccal, polar and non-polar spray containing ondansetron |
| 06/25/2009 | US20090162292 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists |
| 06/25/2009 | US20090162289 A tetrapyrollic photosensitizer compound with one pendant CH2CH2CON(CH2CON(CH2COOH)2)2 or N(CH2COOH)2 group, being a chlorin, bacteriochlorin, porphyrin, pyropheophorbide, purpurinimide, or bacteriopurpurinimide; water soluble photosensitizing and imaging compounds; hyperproliferative tissue |
| 06/25/2009 | US20090162288 Use of modified vaccinia virus strains in combination with a chemotherapeutic agent for use in therapeutic methods |
| 06/25/2009 | US20090162286 Phosphodiesterase 10 Inhibition as Treatment for Obesity-Related and Metabolic Syndrome-Related Conditions |
| 06/25/2009 | US20090162285 Anti-inflammatory fusion protein |
| 06/25/2009 | US20090162283 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 06/25/2009 | US20090162282 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists |
| 06/25/2009 | US20090162281 Radionuclide labeling of Vitamin B12 and Co-enzymes thereof |
| 06/25/2009 | US20090162279 Oligonucleotide or Its Functional Homologue, a Composition Comprising the Same and a Method of Treating B Cell Neoplasm |
| 06/25/2009 | DE102008062373A1 Mittel, mit mindestens einem Wirkstoff, der eine Zahnfleischwachstumswirkung aufweist Means, with at least one active ingredient that comprises a gum growth effect |
| 06/25/2009 | DE102007063671A1 Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New crystalline Diphenylazetidinonhydrate, pharmaceutical compositions containing them and their use |
| 06/25/2009 | DE102007063210A1 Arzneimittel zur Behandlung von Phantomphänomenen Drugs for treatment of phantom phenomena |
| 06/25/2009 | DE102007062550A1 Perhydrochinoxalin-Derivate Perhydroquinoxaline derivatives |
| 06/25/2009 | DE102007061963A1 Pyridazinonderivate Pyridazinone derivatives |
| 06/25/2009 | DE102007061797A1 Method for gestagen treatment of hyperplastic process in endometrium, comprises selecting individual case-specific preparation, producing cytosolic fraction, detecting progesterone receptor level and measuring extent of specific binding |
| 06/25/2009 | DE102007061766A1 New 4-(4-cyano-2-thioaryl)-dihydro-pyrimidinone compounds are human neutrophil elastase inhibitor, useful for the treatment or prevention of e.g. pulmonary arterial hypertonia, acute lung injury and diseases of the cardiovascular system |
| 06/25/2009 | DE102007061764A1 Anellierte Cyanopyridine und ihre Verwendung Fused cyanopyridines and their use |
| 06/25/2009 | DE102007061763A1 Substituierte azabicyclische Verbindungen und ihre Verwendung Substituted azabicyclic compounds and their use |
| 06/25/2009 | DE102007061757A1 Substituierte 2-Phenylpyrimidin-5-carbonsäuren und ihre Verwendung Substituted 2-phenyl-pyrimidine-5-carboxylic acids and their use |
| 06/25/2009 | DE102007061756A1 Substituierte 4-Aminopyrimidin-5-carbonsäuren und ihre Verwendung Substituted 4-aminopyrimidine-5-carboxylic acids and their use |
| 06/25/2009 | DE102007061630A1 Preparing montelukast sodium, useful e.g. to antagonize leukotriene, comprises reacting sodium alkoxide compound with montelukast acid in organic solvent, where the montelukast acid is obtained by acidifying montelukast cyclohexylamine |
| 06/25/2009 | DE102007061262A1 Neue Verwendung von Tribendimidin New use of Tribendimidin |
| 06/25/2009 | DE102007060172A1 New nitrogen substituted heterocyclic compounds are glycogen synthase kinase 3-beta inhibitors useful e.g. to treat and/or prevent hematological disease, preferably leukopenia, and for ex-vivo increase of adult hematopoietic stem cells |
| 06/25/2009 | CA2747095A1 Optical correction |
| 06/25/2009 | CA2711961A1 Transcutaneous pharmaceutical compositions containing a steroid hormone |
| 06/25/2009 | CA2710006A1 Octahydroquinoli zines for antidiabetic treatment |
| 06/25/2009 | CA2709918A1 Benzopyrans and analogs as rho kinase inhibitors |
| 06/25/2009 | CA2709905A1 Pharmaceutical composition |
| 06/25/2009 | CA2709903A1 Pharmaceutical composition |
| 06/25/2009 | CA2709883A1 Benzimidazoles and analogs as rho kinase inhibitors |
| 06/25/2009 | CA2709862A1 Sinomenine derivatives and processes for their synthesis |
| 06/25/2009 | CA2709821A1 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators |
| 06/25/2009 | CA2709816A1 Isothiazolidine 1,1-dioxide and tetrahydro-2h-1,2-thiazine 1,1-dioxide derivatives as p2x7 modulators |
| 06/25/2009 | CA2709749A1 3-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]-tetrazine-8-carboxylic acid amides and their use |
| 06/25/2009 | CA2709579A1 Materials and methods for treatment of pathological ocular vascular proliferation |
| 06/25/2009 | CA2709566A1 Stem-like cells and method for reprogramming adult mammalian somatic cells |
| 06/25/2009 | CA2709553A1 Compound inducing angiogenesis response in ischaemic tissues |
| 06/25/2009 | CA2709407A1 Anthelmintic agents and their use |
| 06/25/2009 | CA2709396A1 Prevention of opportunistic infections in immune-compromised subjects |
| 06/25/2009 | CA2709274A1 Novel compounds useful in therapeutic and cosmetic methods |
| 06/25/2009 | CA2709187A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
| 06/25/2009 | CA2709186A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
| 06/25/2009 | CA2709176A1 Reverse transcriptase inhibitors |
| 06/25/2009 | CA2709126A1 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 06/25/2009 | CA2709119A1 Preventive or therapeutic agent for inflammatory bowel diseases |
| 06/25/2009 | CA2709089A1 Macrocyclic oximyl hepatitis c serine protease inhibitors |
| 06/25/2009 | CA2709081A1 Cyclopropyl amine derivatives |
| 06/25/2009 | CA2709068A1 Benzofuran anilide histone deacetylase inhibitors |
| 06/25/2009 | CA2708866A1 Bicyclic heterocyclic derivative |
| 06/25/2009 | CA2708822A1 Kinesin inhibitors as cancer therapeutics |
| 06/25/2009 | CA2708791A1 Novel imidazole-substituted arylamides |
| 06/25/2009 | CA2708786A1 Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter |
| 06/25/2009 | CA2708785A1 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine |
| 06/25/2009 | CA2708761A1 Compositions and methods for treating and preventing skeletal muscle deficiencies |
| 06/25/2009 | CA2708679A1 Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer |
| 06/25/2009 | CA2708654A1 Breast cancer treatment and treatment prediction |
| 06/25/2009 | CA2708409A1 Process for recovering flunixin from pharmaceutical compositions |
| 06/25/2009 | CA2708391A1 Ppar-delta ligands and methods of their use |
| 06/25/2009 | CA2708361A1 Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives |
| 06/25/2009 | CA2708324A1 Viral polymerase inhibitors |
| 06/25/2009 | CA2708228A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists |
| 06/25/2009 | CA2708118A1 Mineralocorticoid receptor modulators |
| 06/25/2009 | CA2708113A1 Compounds for use in the treatment of cancer |
| 06/25/2009 | CA2707990A1 Leukotriene b4 inhibitors |
| 06/25/2009 | CA2707988A1 Novel pyrazole-substituted arylamides |
| 06/25/2009 | CA2707980A1 Misuse preventative, controlled release formulation |
| 06/25/2009 | CA2707785A1 Indoles and their therapeutic use |
| 06/25/2009 | CA2707768A1 Topical compositions comprising non-proteogenic amino acids and methods of treating skin |
| 06/25/2009 | CA2707615A1 Azolylmethyloxiranes, their use and compositions comprising them |
| 06/25/2009 | CA2707513A1 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |